HCA Healthcare, Inc. (HCA) Options Risk Score
Real-time risk analysis for HCA options traders — updated every 30 minutes.
Data last updated: 2026-07-23
Run a full HCA options risk analysis
See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.
Scan HCA Now — Free →
Is it risky to sell options on HCA Healthcare, Inc. (HCA) right now?
Over a 4-week expiry window, HCA Healthcare, Inc. (HCA) scores 100 out of 100 for options catalyst risk (HIGH). The contributing signals are an upcoming earnings report, 7 recent news items, 10 active legal filings and 60 clinical-trial catalysts within the 4-week window. Anything at 70 or above counts as HIGH, meaning the premium on HCA is at least partly compensation for a scheduled event rather than pure time value. It says nothing about direction — only that something is on the calendar.
HCA shows an IV Rank of 100 — implied volatility is near the top of its own one-year range, so HCA options are historically expensive, which favours premium-selling strategies, with a current implied volatility of about 161%. IV Rank is the most useful figure for deciding whether to sell or buy premium on HCA.
The 2026-07-24 earnings report sits inside a standard monthly expiry for HCA, so implied volatility should stay bid into the date and drop sharply once it passes.
TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer